Physician profile
Shawn E Young
NPI 1437209822
$10,093.11
in general payments reported to CMS, 2019-2025
15 companies · $69.02 in 2025
The $69.02 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $218 · 2020: $3,761 · 2021: $82.71 · 2022: $137 · 2023: $3,258 · 2024: $2,568 · 2025: $69.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,220 · Food and Beverage: $675.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,220.00 |
| Food and Beverage | $674.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $5,220.00 | 2023-2024 | Gilotrif |
| Intuitive Surgical, INC. | $3,217.58 | 2019-2020 | |
| Covidien Lp | $675.00 | 2020 | |
| Abbvie INC. | $346.11 | 2021-2024 | Creon |
| Aroa Biosurgery Incorporated | $133.49 | 2022-2024 | |
| Merit Medical Systems INC | $96.00 | 2023 | Savi Scout |
| Davol INC. | $88.90 | 2022 | |
| Angiodynamics, INC. | $86.15 | 2020 | |
| Hologic Sales and Service, LLC | $74.54 | 2023-2024 | Trunode |
| Medtronic, INC. | $41.15 | 2022-2024 | Signia |
| Teleflex LLC | $37.53 | 2025 | Quikclot |
| Stryker Corporation | $26.73 | 2023 | Spy-Phi System |
| Integra Lifesciences Corporation | $20.91 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Springworks Therapeutics, INC. | $18.44 | 2024 | Ogsiveo |
| Iovance Biotherapeutics, INC. | $10.58 | 2025 | Amtagvi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shawn Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.